Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 29, 2019
Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trialsSusan Stienen, Patrick Rossignol, António Barros, et al.
International Journal of Cardiology|March 7, 2021
Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunctionSusan Stienen, João Pedro Ferreira, Christian Bär, et al.
American Heart Journal|September 20, 2015
Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysisKhibar Salah, Yigal M Pinto, Luc W Eurlings, et al.
Heart Failure Reviews|August 13, 2020
Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approachesSusan Stienen, Ankeet Bhatt, João Pedro Ferreira, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2019
Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction InitiativeSusan Stienen, João Pedro Ferreira, Nicolas Girerd, et al.
Heart (British Cardiac Society)|April 10, 2019
Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fractionKhibar Salah, Susan Stienen, Yigal M Pinto, et al.
Journal of Cardiac Failure|July 29, 2015
N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of TreatmentSusan Stienen, Khibar Salah, Cathelijne Dickhoff, et al.
JACC. Heart Failure|October 11, 2020
Estimating the Lifetime Benefits of Treatments for Heart FailureJoão Pedro Ferreira, Kieran F Docherty, Susan Stienen, et al.
JACC. Heart Failure|July 11, 2016
Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure PatientsSusan Stienen, Khibar Salah, Luc W Eurlings, et al.
European Journal of Heart Failure|July 30, 2015
Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?Susan Stienen, Khibar Salah, Luc W M Eurlings, et al.
Pageof 2